We compared the efficacy and safety of pramipexole (PPX) with placebo in the treatment of advanced Parkinson's disease (PD) as an adjunct to levodopa. A bromocriptine (BR) group was included to enable determination of the noninferiority of PPX relative to BR as the standard treatment.
- Drug comparison
- Parkinson's disease
- Randomized controlled trial (RCT)
ASJC Scopus subject areas
- Clinical Neurology